Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination

MELBOURNE, Australia - CSL today announced its continued partnership with the National Youth Science Forum (NYSF) signing a new three-year agreement in support of programs that encourage life-long STEM literacy.

CSL Limited today announced that it will present at the 2019 J.P. Morgan Annual Healthcare Conference. CEO and Managing Director Paul Perreault will present the company’s overview on Wednesday, January 9 at 8:30 a.m. Pacific time.

The Honourable John Brumby AO today formally opened the new ‘Nancy Millis’ building, an expansion of the Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, incorporating CSL’s Global Hub for Research and Translational Medicine.

CSL spotlights developments in cell-based vaccine technology at Australian Research and Development briefing

Two Australian scientists have each been awarded an AUD$1.25 million, five-year, CSL Centenary Fellowship to further research into why so many people die from infection following stroke and how we might develop better vaccines against diseases such as tuberculosis.